Carl P. Sherr & Co., LLC Bristol Myers Squibb CO Transaction History

Carl P. Sherr & Co., LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$68.48 - $81.09 $8,902 - $10,541	130 Added 1.77%	7,469 $537,000
Q2 2022 Aug 03, 2022	BUY	$72.62 - $79.98 $21,786 - $23,994	300 Added 4.26%	7,339 $565,000
Q1 2022 May 03, 2022	SELL	$61.48 - $73.72 $18,444 - $22,116	-300 Reduced 4.09%	7,039 $514,000
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $4,022 - $4,689	75 Added 1.03%	7,339 $458,000
Q1 2021 Apr 13, 2021	SELL	$59.34 - $66.74 $59,755 - $67,207	-1,007 Reduced 12.18%	7,264 $459,000
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $2,887 - $3,271	-50 Reduced 0.6%	8,271 $513,000
Q4 2019 Jul 28, 2020	BUY	$49.21 - $64.19 $409,476 - $534,124	8,321 New	8,321 $534,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Carl P. Sherr & Co., LLC, based on Form 13F filings with the SEC.

Stay updated on Carl P. Sherr & Co., LLC with notifications on news.